343 related articles for article (PubMed ID: 17420163)
1. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Pericacho M; Rodriguez-Barbero A; Eleno N; Lopez-Novoa JM; Düwell A; Vega MA; Bernabeu C; Botella LM
Hum Mol Genet; 2007 Jul; 16(13):1515-33. PubMed ID: 17420163
[TBL] [Abstract][Full Text] [Related]
2. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management.
Stuhrmann M; El-Harith el-HA
Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283
[TBL] [Abstract][Full Text] [Related]
3. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
[TBL] [Abstract][Full Text] [Related]
4. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling.
Seki T; Yun J; Oh SP
Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115
[TBL] [Abstract][Full Text] [Related]
5. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor function in the endothelium.
Lebrin F; Deckers M; Bertolino P; Ten Dijke P
Cardiovasc Res; 2005 Feb; 65(3):599-608. PubMed ID: 15664386
[TBL] [Abstract][Full Text] [Related]
7. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.
Ota T; Fujii M; Sugizaki T; Ishii M; Miyazawa K; Aburatani H; Miyazono K
J Cell Physiol; 2002 Dec; 193(3):299-318. PubMed ID: 12384983
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia].
Peng HL; Hu GY; Zhang GS; Gong FJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429
[TBL] [Abstract][Full Text] [Related]
9. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
[TBL] [Abstract][Full Text] [Related]
10. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
[TBL] [Abstract][Full Text] [Related]
11. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.
Carvalho RL; Jonker L; Goumans MJ; Larsson J; Bouwman P; Karlsson S; Dijke PT; Arthur HM; Mummery CL
Development; 2004 Dec; 131(24):6237-47. PubMed ID: 15548578
[TBL] [Abstract][Full Text] [Related]
12. MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells.
Tabruyn SP; Hansen S; Ojeda-Fernández ML; Bovy N; Zarrabeitia R; Recio-Poveda L; Bernabéu C; Martial JA; Botella LM; Struman I
Angiogenesis; 2013 Oct; 16(4):877-87. PubMed ID: 23800974
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment.
Haitjema T; Westermann CJ; Overtoom TT; Timmer R; Disch F; Mauser H; Lammers JW
Arch Intern Med; 1996 Apr; 156(7):714-9. PubMed ID: 8615703
[TBL] [Abstract][Full Text] [Related]
14. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary hemorragic telangiectasia: the state of art].
Colotto M; Castellano V; Anatra GM; Borgia MC
Clin Ter; 2007; 158(3):253-60. PubMed ID: 17612287
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
[TBL] [Abstract][Full Text] [Related]
17. Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT).
Ojeda-Fernandez L; Barrios L; Rodriguez-Barbero A; Recio-Poveda L; Bernabeu C; Botella LM
Clin Chim Acta; 2010 Apr; 411(7-8):494-9. PubMed ID: 20067780
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary hemorrhagic telangiectasia].
Plauchu H; Dupuis-Girod S
Rev Prat; 2009 Sep; 59(7):899-903. PubMed ID: 19839452
[TBL] [Abstract][Full Text] [Related]
19. Isolation of a regulatory region of activin receptor-like kinase 1 gene sufficient for arterial endothelium-specific expression.
Seki T; Hong KH; Yun J; Kim SJ; Oh SP
Circ Res; 2004 Apr; 94(8):e72-7. PubMed ID: 15059937
[TBL] [Abstract][Full Text] [Related]
20. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
